Who is sponsoring NCT05920369?

NCT05920369 is sponsored by Cairo University.

What drugs are being tested in NCT05920369?

Interventions in NCT05920369: low-energy extracorporeal shockwave and a tailored exercise program, low-energy extracorporeal shockwave, tailored exercise program.

What condition does NCT05920369 study?

NCT05920369 studies Axillary Web Syndrome.

Is NCT05920369 still recruiting?

NCT05920369 is currently status unknown. Last updated 27 June 2023.

Last reviewed 2023-06-27 · How we verify

NCT05920369

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Extracorporeal Shock Wave and a Tailored Exercise Program on Axillary Web Syndrome

Status unknown NA Last updated 27 June 2023

What this trial tests

NA trial testing low-energy extracorporeal shockwave and a tailored exercise program in Axillary Web Syndrome in 93 participants. Status unknown.

Timeline

15 April 2023

Primary endpoint
1 August 2023

1 September 2023

Quick facts

Lead sponsor	Cairo University
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	93
Start date	15 April 2023
Primary completion	1 August 2023
Estimated completion	1 September 2023
Sites	2 locations across Egypt

Drugs / interventions tested

low-energy extracorporeal shockwave and a tailored exercise program
low-energy extracorporeal shockwave
tailored exercise program

Conditions studied

Axillary Web Syndrome — all drugs for Axillary Web Syndrome →

Sponsor

Cairo University

Who can join

Adults 40 to 65, female only, with Axillary Web Syndrome. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A total of 93 suitable patients will be randomly allocated into three groups: Group A will receive both low-energy extracorporeal shock wave therapy and a tailored exercise program, Group B will receive only low-energy extracorporeal shock wave therapy, and Group C will receive only the tailored exercise program.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Axillary Web Syndrome

Currently open trials in the same condition.

NCT07236658 — Deep Learning for Musculoskeletal Complications in Breast Cancer · recruiting

Other Cairo University trials

Trials by the same sponsor.

NCT04155528 — Effect of Music Therapy on Postoperative Health Outcomes · NA · not yet recruiting
NCT07363239 — CBCT-Based Safety Distance for Implant Placement Near the Inferior Alveolar Canal · not yet recruiting
NCT07374575 — Egyptian Dental Professionals' Perspectives on the Oral Microbiome and Exosomes · not yet recruiting
NCT07381153 — In-Vitro Cytotoxicity Assessment of INOX (Nanoksa G Plus) Polymer Discs · not yet recruiting
NCT07375394 — 3D-Printed Extraoral Camera for Standardized Dental Photography · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05920369 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Cairo University
Last refreshed: 27 June 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05920369.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing